Avery, R. K., Bolwell, B. J., Yen-Lieberman, B., Lurain, N., Waldman, W. J., Longworth, D. L., … Williams, J. W. (2004). Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection. Bone Marrow Transplantation, 34(12), 1071–1075. https://doi.org/10.1038/sj.bmt.1704694

Avery, R. K., B. J. Bolwell, B. Yen-Lieberman, N. Lurain, W. J. Waldman, D. L. Longworth, A. J. Taege, et al. “Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection.” Bone Marrow Transplantation 34, no. 12 (December 1, 2004): 1071–75. https://doi.org/10.1038/sj.bmt.1704694.

Avery RK, Bolwell BJ, Yen-Lieberman B, Lurain N, Waldman WJ, Longworth DL, et al. Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection. Bone Marrow Transplantation. 2004 Dec 1;34(12):1071–5.

Avery, R. K., et al. “Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection.” Bone Marrow Transplantation, vol. 34, no. 12, Springer Science and Business Media LLC, Dec. 2004, pp. 1071–75. Crossref, doi:10.1038/sj.bmt.1704694.

Avery RK, Bolwell BJ, Yen-Lieberman B, Lurain N, Waldman WJ, Longworth DL, Taege AJ, Mossad SB, Kohn D, Long JR, Curtis J, Kalaycio M, Pohlman B, Williams JW. Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection. Bone Marrow Transplantation. Springer Science and Business Media LLC; 2004 Dec 1;34(12):1071–1075.